Firms

Bioluminescence Ventures
Bioluminescence Ventures (BLV) is a San Francisco biotechnology venture manager founded by Kouki Harasaki. Its documented strategy supported breakthrough biology, drug-discovery platforms, genetic medicines and computational biology, including neuroscience drug development. Its historical portfolio includes Cerevance, Ensoma, Nido Biosciences, ReCode Therapeutics, SURGE Therapeutics and GEMMABio. The firm emerged from stealth in November2023 reporting USD477M assets under management across two separately registered Delaware funds; that AUM is not an additional cash raise. Primary SEC filings independently document USD350M and USD127,123,383 fund interests sold. This profile preserves the firm’s historical investment activity and dated team roster. Asof October7,2026, its original domain redirects to a parked-domain sale page, and current professional biographies identify several published partners as former BLV staff. Continuing operations, a current team and new-investment activity cannot be confirmed from a live manager website. The archived logo, biographies and portfolio are identified as historical publisher material, rather than a current operating-directory claim.
- Founded
- —
- Type
- Venture capital















